Dual-agent immunotherapy for prevention of melanoma brain metastases: A real-world analysis of 8686 patients.

被引：0
|
作者：
Mansouri, Alireza
Bhanja, Debarati
Wilding, Hannah E.
Mikolajewicz, Nicholas
Ozair, Ahmad
Ahluwalia, Manmeet Singh
机构：
[1] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[2] Penn State Coll Med, Hershey, PA USA
[3] Penn State Coll Med, University Pk, PA USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Miami Canc Inst, Baptist Hlth South Florida, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2022
引用
收藏
页数：1
相关论文
共 50 条
  • [1] IS DUAL AGENT IMMUNOTHERAPY SHIFTING THE EPIDEMIOLOGY OF MELANOMA BRAIN METASTASES? A REAL-WORLD ANALYSIS AND SINGLE-INSTITUTION VALIDATION
    Bhanja, Debarati
    Wilding, Hannah
    Moeckel, Camille
    Hong, Jinpyo
    Baroz, Angel
    Stahl, Caleb
    Ozair, Ahmad
    Dao, Joseph
    Sivik, Jeff
    Drabick, Joseph
    Pameijer, Colette
    Ahluwalia, Manmeet
    Mansouri, Alireza
    NEURO-ONCOLOGY, 2023, 25
  • [2] Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand
    Walsh, Niamh
    Stephens, Rosalie
    Tan, Alvin
    Durandt, Vanessa
    Mclachlan, Jennifer
    Jordan, Jody
    Gregory, Kate
    Sutton, Sean
    Barrow, Catherine
    Wong, Annie N. M.
    JCO ONCOLOGY PRACTICE, 2025, 21 (03)
  • [3] Impact of SRS to melanoma brain metastases associated with immunotherapy on OS: real-world evidence
    Castro, D.
    Teixeira, C. H.
    Gondim, G.
    Aguilar, P.
    Costa, M. A.
    Jorge, T. W.
    Hanriot, R.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S977 - S978
  • [4] Real-world data on melanoma brain metastases and survival outcome
    Pedersen, Sidsel
    Moller, Soren
    Donia, Marco
    Persson, Gitte Fredberg
    Svane, Inge Marie
    Ellebaek, Eva
    MELANOMA RESEARCH, 2022, 32 (03) : 173 - 182
  • [5] Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
    Yang Wang
    Bin Lian
    Lu Si
    ZhiHong Chi
    XiNan Sheng
    Xuan Wang
    LiLi Mao
    BiXia Tang
    SiMing Li
    XieQiao Yan
    Xue Bai
    Li Zhou
    ChuanLiang Cui
    Jun Guo
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2731 - 2740
  • [6] Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases
    Berking, C.
    Schadendorf, D.
    Weichenthal, M.
    Eigentler, T.
    Mohr, P.
    Schober, K.
    Kiecker, F.
    Loquai, C.
    Debus, D.
    Gutzmer, R.
    Leiter-Stoeppke, U.
    ANNALS OF ONCOLOGY, 2020, 31 : S755 - S755
  • [7] Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
    Wang, Yang
    Lian, Bin
    Si, Lu
    Chi, ZhiHong
    Sheng, XiNan
    Wang, Xuan
    Mao, LiLi
    Tang, BiXia
    Li, SiMing
    Yan, XieQiao
    Bai, Xue
    Zhou, Li
    Cui, ChuanLiang
    Guo, Jun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2731 - 2740
  • [8] Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
    Moyers, Justin T.
    Chong, Esther G.
    Peng, Jiahao
    Tsai, Hsin Hsiang Clarence
    Sufficool, Daniel
    Shavlik, David
    Nagaraj, Gayathri
    CANCER MEDICINE, 2021, 10 (04): : 1201 - 1211
  • [9] Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort
    Kattenhoj, Karoline Dreyer
    Moberg, Christine Louise
    Guldbrandt, Louise Mahncke
    Friis, Rasmus Blechingberg
    Mapendano, Christophe Kamungu
    Petersen, Soren Kjaer
    Ruhlmann, Christina Halgaard Bruvik
    Svane, Inge Marie
    Donia, Marco
    Ellebaek, Eva
    Schmidt, Henrik
    CANCERS, 2024, 16 (14)
  • [10] Impact of cranial stereotactic radiotherapy associated with immunotherapy with nivolumab and ipilimumab on overall survival in patients with melanoma brain metastases: a real-world evidence
    Douglas Guedes de Castro
    Carlos Henrique Andrade Teixeira
    Guilherme Rocha Melo Gondim
    Patrícia Bailão Aguilar
    Marcos André de Sá Barreto Costa
    Thiago William Carnier Jorge
    Rodrigo de Morais Hanriot
    Clinical and Translational Oncology, 2022, 24 : 1828 - 1830
12345